•  
  •  
 

Nursing & Health Sciences Research Journal

Abstract

Introduction: COVID-19 had a profound impact on cancer screening, diagnosis, and treatment worldwide. The purpose of this study was to examine the role that the COVID-19 pandemic had on delays in breast cancer screening, diagnosis, treatment, and other related variables, including cancer staging and oncology measures of performance (ECOG Performance Status), in the inpatient and ambulatory oncology settings.

Methods: This was a multi-site, interdisciplinary retrospective review study including 1,514 participants. Four cancer centers collaborated, submitting de-identified data in accordance with their policies and procedures.

Results: Our study's results showed significantly higher delays in screening mammogram appointments (p < .001) during the COVID-19 pandemic (N=142) than before the COVID-19 pandemic (N=56), with a 52% higher likelihood of canceling screening mammogram appointments during COVID-19. Our findings also revealed a statistically significant difference (p < .001) in the time from diagnosis to the first recommended treatment for scheduled initially appointments, with an increase of 18 days, suggesting delays in cancer treatment during the COVID-19 pandemic.

Discussion: Our findings contribute valuable insights into breast cancer screening, diagnosis, and treatment delays pre- and during COVID-19. More research is needed to investigate outcomes associated with delays in breast cancer screening, diagnosis, and treatment during COVID-19. The long-term impact of the COVID-19 delays in screening, diagnosis, and treatment of breast cancer is important knowledge that can guide healthcare providers in ensuring the best care for their individuals during a pandemic.

Download

Included in

Nursing Commons

Share

COinS